Fischli Fund supports research on fructose metabolism
With another donation, the Walter & Edith Fischli Fund supports the work of Prof. Wilhelm Krek's research group on the connection between fructose metabolism and cancer development.
Already in 2015 Dr. Walter Fischli, co-founder of the biopharmaceutical company Actelion, supported the work of the research group of Prof. Wilhelm Krek after its breakthrough in the field of fructose metabolism with a generous donation. More information about the current state of research in this field can be found in an external page article by the ETH Foundation.
Link to the Krek website.